Risk of harm from use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients pre or post bariatric surgery

  • Mitesh Sharma
  • , Rahul Nayar
  • , Yitka Graham
  • , Helen M Parretti
  • , Sally Abbott
  • , Abd Tahrani
  • , Alexander D Miras
  • , Brijesh Madhok
  • , Rishi Singhal
  • , Kamal Mahawar

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)2469-2470
Number of pages2
JournalObesity surgery
Volume32
Issue number7
Early online date28 Apr 2022
DOIs
Publication statusPublished - Jul 2022

Keywords

  • Bariatric Surgery/adverse effects
  • Diabetes Mellitus, Type 2/drug therapy
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Obesity, Morbid/surgery
  • Sodium
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors/adverse effects

Cite this